Lung cancer drug under the microscope: how does cemiplimab perform in real life?

NCT ID NCT05363319

Recruiting now Knowledge-focused Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 35 times

Summary

This study follows 500 European patients with advanced non-small cell lung cancer who are already prescribed cemiplimab (Libtayo) as part of their normal care. Researchers will track how long patients live, how well the cancer responds, and any side effects. The goal is to see if the drug works as well in everyday clinics as it did in earlier clinical trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

AO Universitaria Policlinico Vittorio Emanuele
RECRUITING

Catania, 95123, Italy
AORN dei Colli
RECRUITING

Naples, 80131, Italy
AOU Careggi
RECRUITING

Florence, Firenze, 50134, Italy
APHM - Hopital Nord
RECRUITING

Marseille, Bouches-du-Rhône, 13915, France
Agaplesion Diakonieklinikum Rotenburg
RECRUITING

Rotenburg (Wümme), Lower Saxony, 27356, Germany
Azienda Ospedaliero-Universitaria di Modena
RECRUITING

Modena, 41124, Italy
Azienda Sanitaria Locale (ASL) Taranto
RECRUITING

Taranto, 74010, Italy
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) Santa Maria della Misericordia
RECRUITING

Udine, 33100, Italy
Center Hospitalier Universitaire (CHU) of Clermont
RECRUITING

Clermont-Ferrand, 63003, France
Centre Hospitalier - Le mans
RECRUITING

Le Mans, 72037, France
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITING

Poitiers, New Aquitaine, 86021, France
Centre Hospitalier Universitaire Angers
RECRUITING

Angers, 49000, France
Complejo Hospitalario Universitario de Ferrol - Hospital Naval
RECRUITING

Ferrol, Galicia, 15405, Spain
Consorcio Hospitalario Provincial de Castellon
RECRUITING

Castellon, Castellon, 12002, Spain
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITING

Milan, 20133, Italy
Fondazione IRCCS Policlinico San Matteo
RECRUITING

Pavia, 27100, Italy
Franziskus Hospital Harderberg
RECRUITING

Georgsmarienhütte, Georgsmarienhuette, 49124, Germany
Gemeinschaftskrankenhaus Havelhoehe
RECRUITING

Berlin, 14089, Germany
Gesellschaft fur Onkologische Studien Dortmund mbH (Gefos)
RECRUITING

Dortmund, 44263, Germany
Haematologisch Onkologische Schwerpunktpraxis - Troisdorf
RECRUITING

Troisdorf, North Rhine-Westphalia, 53840, Germany
Hopital Tenon
RECRUITING

Paris, 75020, France
Hopitaux Universitaires de Strasbourg
RECRUITING

Strasbourg, 67091, France
Hospital Arnau de Vilanova
RECRUITING

Lleida, 25198, Spain
Hospital Torrecardenas
RECRUITING

Almería, 04009, Spain
Hospital Universitari Sant Joan de Reus
RECRUITING

Tarragona, 43204, Spain
Hospital Universitario Alvaro Cunqueiro
RECRUITING

Vigo, Galicia, 36204, Spain
Hospital Universitario De Jerez
RECRUITING

Jerez de la Frontera, Cadiz, 11407, Spain
Hospital Universitario Nuestra Senora de Candelaria
RECRUITING

Santa Cruz de Tenerife, 38010, Spain
Hospital Universitario Virgen De La Victoria Malaga
RECRUITING

Málaga, Andalusia, 29010, Spain
Humanitas Istituto Clinico Catanese
RECRUITING

Misterbianco, Catania, 95065, Italy
IRCCS Humanitas Research Hospital
RECRUITING

Rozzano, Milan, 20089, Italy
Istituto Nazionale Tumori IRCCS Fondazione G Pascale
RECRUITING

Naples, 80131, Italy
Klinikum Chemnitz gGmbH
WITHDRAWN

Chemnitz, Saxony, 09116, Germany
Klinikum Klagenfurt
RECRUITING

Klagenfurt, Carinthia, 9020, Austria
Klinikum Konstanz
RECRUITING

Konstanz, Baden-Wurttemberg, 78464, Germany
Krankenhaus Martha-Maria Halle-Doelau gGmbH
RECRUITING

Halle, 06120, Germany
Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital
RECRUITING

Mulhouse, Alsace, 68100, France
Marienhaus Klinikum Mainz
WITHDRAWN

Mainz, 55131, Germany
MedFISMO
WITHDRAWN

Weinsberg, Baden-Wurttemberg, 74189, Germany
Nuremberg Hospital, Campus North
RECRUITING

Nuremberg, 90419, Germany
Ospedale Di Cisanello Azienda Ospedaliero Universitaria
RECRUITING

Pisa, Tuscany, 56126, Italy
Parc Tauli Sabadell Hospital Universitari
RECRUITING

Sabadell, Barcelona, 08208, Spain
Pneumologische Praxis PD Dr. Med Christian Gessner
RECRUITING

Leipzig, Saxony, 4347, Germany
Sainte Catherine Institut du Cancer Avignon Provence
RECRUITING

Avignon, Vaucluse, 84918, France
Salzburger Landeskliniken (SALK)
RECRUITING

Salzburg, 5020, Austria
San Luigi Gonzaga University Hospital
RECRUITING

Orbassano, Piedmont, 10043, Italy
St. Franziskus Hospital Münster
RECRUITING

Münster, North Rhine-Westphalia, 48145, Germany
Staedtisches Klinikum Muenchen Bogenhausen
RECRUITING

München, Bavaria, 81925, Germany
University Hospital of Jaen
RECRUITING

Jaén, 23007, Spain

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cemiplimab (Libtayo) with or without platinum-based chemotherapy

What this could lead to

If successful, this study could confirm that cemiplimab works well in everyday clinical practice, not just in controlled trials, for advanced lung cancer.

What could go wrong

This is an observational study, not a controlled experiment, so results may be less reliable. It only looks at patients already prescribed the drug, so it cannot prove cause and effect.

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER